Your browser doesn't support javascript.
loading
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Urrutia, Samuel; Chien, Kelly S; Li, Ziyi; Bataller, Alex; Almanza, Emmanuel; Sasaki, Koji; Montalban-Bravo, Guillermo; Short, Nicholas J; Jabbour, Elias; Kadia, Tapan M; Ravandi, Farhad; Borthakur, Gautam; Alvarado, Yesid; Daver, Naval; Kanagal-Shamanna, Rashmi; Bueso-Ramos, Carlos; Pierce, Sherry A; Kantarjian, Hagop; Garcia-Manero, Guillermo.
Affiliation
  • Urrutia S; Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas, USA.
  • Chien KS; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Li Z; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA.
  • Bataller A; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Almanza E; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Sasaki K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Montalban-Bravo G; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Short NJ; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Alvarado Y; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Bueso-Ramos C; Department of Hematopathology, MD Anderson Cancer Center, Houston, Texas, USA.
  • Pierce SA; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 98(10): E281-E284, 2023 10.
Article in En | MEDLINE | ID: mdl-37515433
ABSTRACT
Evaluation of IPSS-M and exploratory prognostic model for MDS at the time of HMA failure.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes Type of study: Prognostic_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2023 Type: Article Affiliation country: United States